Digital health innovator Axomove has successfully secured €4 million in a Series A funding round to advance its telerehabilitation platform. The investment was co-led by Bpifrance's Digital Prevention Fund and Go Capital, signaling strong confidence in the company's mission. This new capital will fuel the commercial expansion of its solution for preventing and treating musculoskeletal disorders.
Strategic Investment for Market Expansion
The funding round was co-directed by Bpifrance, through its Digital Prevention Fund, and Go Capital, with participation from Inco Ventures and historic investor Faraday Venture Partners. This significant backing from prominent institutional investors validates Axomove's strategic direction and its established market relevance. The investment is poised to accelerate the company's growth trajectory and solidify its position in the e-health sector.
Founded in 2017, Axomove offers a comprehensive digital platform for medical remote monitoring, focusing on prevention and rehabilitation. The solution provides therapeutic exercise video sessions and remote access to healthcare professionals for ongoing support. It serves a diverse client base including healthcare facilities, insurance companies, and large corporations to address musculoskeletal health.
A Proven Model with Significant Traction
Axomove has demonstrated substantial market traction, currently serving 150 B2B clients such as Air France, Thales, and the Lille University Hospital. This extensive network provides its services to 75,000 users, showcasing the platform's widespread adoption and impact. Notably, its program for low back pain is already reimbursed by the French National Health Insurance, a key differentiator.
The company was established by a unique team comprising a physiotherapist, a former professional handball player, and a technology expert. Initially targeting physiotherapy practices to aid in patient follow-up, the company has since broadened its scope significantly. This evolution has transformed Axomove into a leading e-health platform for both preventing musculoskeletal issues and managing patient recovery.
Future Growth and Platform Enhancement
With the new capital, Axomove plans to aggressively scale its commercial operations and double its team of 30 employees within the next three years. A primary focus will be on strengthening its sales force to expand its reach among enterprises, insurers, and healthcare providers. This strategic push is designed to capture a larger share of the growing digital health market.
A key objective for the company is to broaden the scope of reimbursement beyond low back pain to include all musculoskeletal conditions. Axomove also aims to secure coverage for metabolic diseases, such as obesity, further diversifying its therapeutic offerings. This expansion will make its clinically validated programs accessible to a much larger patient population.
Technological innovation remains a core priority, with plans to enrich the platform's user experience through advanced new features. The company intends to integrate motion capture technology and gamification elements to improve patient engagement and adherence to treatment plans. These enhancements aim to make rehabilitation more interactive and effective for all users on the platform.
This €4 million investment marks a pivotal moment for Axomove, empowering it to accelerate its mission of becoming a standard of care in digital therapy. By expanding its commercial footprint and enhancing its technology, the company is well-positioned to deliver significant clinical and economic benefits. Ultimately, Axomove's growth will help improve patient autonomy while reducing costs for the broader healthcare system.